Suchergebnisse - "muscular dystrophy"

PubPharm (13.178)

61

Clinical Trial Readiness for the Dystroglycanopathies : Clinical Trial Readiness for the Dystroglycanopathies

enthalten in: ClinicalTrials.gov | 2024

62

Cycle Exercise in Wheelchair Users With Muscular Dystrophy or Cerebral Palsy : Cycle Exercise in Wheelchair Users With Muscular Dystrophy or Cerebral Palsy

enthalten in: ClinicalTrials.gov | 2024

63

MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants : MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

enthalten in: ClinicalTrials.gov | 2024

64

Nomad P-KAFO Study : Power Forward Study: A Cross-Sector, Multisite Clinical Trial of a Powered Knee-Ankle-Foot Orthosis

enthalten in: ClinicalTrials.gov | 2024

65

Natural History Study of Children With LAMA2-related Dystrophies : A Prospective, Longitudinal, Interventional Natural History Study of Children With LAMA2-related Dystrophies

enthalten in: ClinicalTrials.gov | 2024

66

"I don't know whether I will be alive or not" - An interpretative phenomenological analysis of young adult males with Duchenne Muscular Dystrophy making sense of self and life

enthalten in: Disability and health journal | 2024

von Ee, J. | Chong, P. | Poh, Y. | +2

67

A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy : A Phase 1b, Open-label Study of the Safety and Pharmacokinetics of EDG-5506 in Adults With Becker Muscular Dystrophy

enthalten in: ClinicalTrials.gov | 2024

68

Dystrophin deficiency impairs cell junction formation during embryonic myogenesis

enthalten in: bioRxiv : the preprint server for biology | 2024

von Mozin, E. | Massouridès, E. | Mournetas, V. | +11

69

The Association Between Physical Activity/Heart Rate Variability Data Obtained Using a Wearable Device and Timed Motor Functional Tests in Patients with Duchenne Muscular Dystrophy : A Pilot Study

enthalten in: Journal of neuromuscular diseases | 2024

von Nakamura, A. | Matsumura, T. | Takeshima, Y. | +4

70

Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy : A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF 06939926 FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

enthalten in: ClinicalTrials.gov | 2024